TRIPLE NEGATIVE BREAST NEOPLASMS
Clinical trials for TRIPLE NEGATIVE BREAST NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new TRIPLE NEGATIVE BREAST NEOPLASMS trials appear
Sign up with your email to follow new studies for TRIPLE NEGATIVE BREAST NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough cancers
Disease control OngoingThis early-stage study tests a new drug called KFA115, alone or with pembrolizumab, in people with advanced cancers like lung, skin, kidney, and others. The main goal is to find the safest dose and understand side effects. About 126 participants will be enrolled to see if the tre…
Matched conditions: TRIPLE NEGATIVE BREAST NEOPLASMS
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 00:42 UTC
-
New drug BT8009 targets Hard-to-Treat cancers in early trial
Disease control OngoingThis study tests a new drug called BT8009, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have a protein called Nectin-4. The goal is to see if the drug is safe and shrinks tumors. About 329 adults with cancers like bladder, breast, lung, or…
Matched conditions: TRIPLE NEGATIVE BREAST NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated May 17, 2026 00:29 UTC
-
New drug cocktail shows promise for aggressive breast cancer
Disease control OngoingThis study tests whether combining the immunotherapy drug durvalumab with other cancer treatments (with or without chemotherapy) can help control metastatic triple-negative breast cancer in people who haven't had prior treatment for advanced disease. About 243 women with advanced…
Matched conditions: TRIPLE NEGATIVE BREAST NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
New chemo combo aims to wipe out aggressive breast cancer before surgery
Disease control OngoingThis study tests whether adding the drug capecitabine to standard chemotherapy before surgery can completely eliminate early triple-negative breast cancer. About 325 adults with node-positive or larger tumors are participating. The main goal is to see if the combination leads to …
Matched conditions: TRIPLE NEGATIVE BREAST NEOPLASMS
Phase: PHASE3 • Sponsor: Lund University Hospital • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New hope for hard-to-treat breast cancer: drug combo tested in large trial
Disease control OngoingThis large Phase 3 study tests whether adding the drug capivasertib to standard chemotherapy (paclitaxel) helps people with advanced triple-negative breast cancer live longer. About 923 participants with inoperable or metastatic disease are randomly assigned to receive either the…
Matched conditions: TRIPLE NEGATIVE BREAST NEOPLASMS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC